Amarin Corp Plc (AMRN)

[Biobillionair]

If the FDA doesn't approve Vascepa for accelerated approval I assume they intend to screw Amarin over again and Amarin should be prepared to litigate a R-I label via "Regulatory Takings" claim.

Amarin has the evidence and attorney's to win a monetary judgement against the FDA for taking the high trig on label treatment from Amarin. Suit will be supported by RWE & R-I results; the ANCHOR SPA was unjustly rescinded against professional lipid guidelines at the time. These guidelines happened to be correct and the "significant" science used to rescind ANCHOR was by definition insignificant, the public rescindment was worse than arbitrary and capricious, it was reckless regulatory abuse of power.

BB